Login
← Go Back
Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024
Stock Price vs Company Growth
1d
2.4%
1w
0.4%
1m
13.9%
3m
27.1%
6m
55.6%
1y
60.7%
all
46.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,450 2.4%
1,104
1,476
Company Overview
Sales
2,250 Cr
Growth: 18.0%
Profit after Tax
361 Cr
Growth: 3.7%
Large Cap
30,785 Cr
P/E: 85.6x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 2,250
Growth 18.0%
EBITDA 29.3%
P/S 13.7x
Dividend 0.0%
P/E 85.6x
Book Value ₹ 120
PEG Ratio 4.7x
ROE 14.9%
P/B 12.0x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Belongs to (33 Indices) view more
Followers (1)
varsha96